PCL-PEG-NHS

Price range: $300.00 through $1,200.00

PCL-PEG-NHS is a biodegradable amphiphilic block copolymer consisting of poly(ε-caprolactone) (PCL), polyethylene glycol (PEG), and a terminal N-hydroxysuccinimide (NHS) ester. The hydrophobic PCL segment enables drug encapsulation and sustained release, the PEG spacer improves aqueous solubility and biocompatibility, and the NHS ester provides rapid and efficient conjugation with primary amine-containing biomolecules. PCL-PEG-NHS is widely used in targeted drug delivery, nanoparticle functionalization, biomaterials engineering, and nanomedicine research.

Product Specifications

Product Name: PCL-PEG-NHS
Polymer Composition: Poly(ε-caprolactone)-Polyethylene Glycol-NHS Ester
Molecular Weight: PCL (1k-50k), PEG (1k, 2k, 3.4k, 5k, 10k Da), Custom
Functional Groups: PCL, PEG, NHS Ester
Appearance: White to off-white solid
Solubility: DMSO, DMF, THF, Dichloromethane, Chloroform, Acetone
Storage: -20°C, dry and protected from light
Purity: Typically ≥95%

PCL-PEG-NHS

Description

General Description

PCL-PEG-NHS is a functional biodegradable copolymer designed for nanoparticle engineering and amine-reactive bioconjugation applications. The hydrophobic PCL segment forms the core of nanoparticles and micelles capable of encapsulating hydrophobic drugs, proteins, peptides, and imaging agents, while the PEG segment forms a hydrophilic corona that enhances colloidal stability and reduces nonspecific protein adsorption.

The terminal NHS ester readily reacts with primary amines present on peptides, proteins, antibodies, enzymes, nucleic acids, and targeting ligands under mild conditions to form stable amide bonds. PCL-PEG-NHS is frequently employed in targeted drug delivery systems, nanoparticle surface modification, polymer therapeutics, imaging agents, and advanced biomaterials development.

Applications

  • Drug delivery systems
  • Nanoparticle formulation
  • Polymeric micelle preparation
  • Antibody conjugation
  • Peptide conjugation
  • Protein conjugation
  • Surface modification
  • Targeted drug delivery
  • Tissue engineering
  • Nanomedicine research

Features and Benefits

  • Biodegradable PCL segment
  • Hydrophilic PEG spacer
  • Reactive NHS ester functionality
  • Efficient amine-specific conjugation
  • Forms stable amide linkages
  • Excellent biocompatibility
  • Improves nanoparticle stability
  • Reduces protein adsorption
  • Supports sustained drug release

Additional information

PCL Molecular Weight

1000, 2000, 3000, 4000, 5000, 10k

PEG Molecular Weight

1000, 2000, 3000, 5000

Package size

100mg, 1g